JP2023523438A5 - - Google Patents
Info
- Publication number
- JP2023523438A5 JP2023523438A5 JP2022565827A JP2022565827A JP2023523438A5 JP 2023523438 A5 JP2023523438 A5 JP 2023523438A5 JP 2022565827 A JP2022565827 A JP 2022565827A JP 2022565827 A JP2022565827 A JP 2022565827A JP 2023523438 A5 JP2023523438 A5 JP 2023523438A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- methyl
- carboxamide
- pyridazine
- methoxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063016539P | 2020-04-28 | 2020-04-28 | |
| US63/016,539 | 2020-04-28 | ||
| PCT/US2021/029272 WO2021222153A1 (en) | 2020-04-28 | 2021-04-27 | Substituted n-(methyl-d3)pyridazine-3-carboxamide or n-(methyl-d3)-nicotinamide compounds as il-12, il-23 and/or ifnalpha modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023523438A JP2023523438A (ja) | 2023-06-05 |
| JP2023523438A5 true JP2023523438A5 (https=) | 2024-05-10 |
Family
ID=75905074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022565827A Pending JP2023523438A (ja) | 2020-04-28 | 2021-04-27 | 置換ヘテロ環式化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12479831B2 (https=) |
| EP (1) | EP4143180A1 (https=) |
| JP (1) | JP2023523438A (https=) |
| KR (1) | KR20230004771A (https=) |
| CN (1) | CN115715287A (https=) |
| WO (1) | WO2021222153A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12492184B2 (en) | 2020-12-22 | 2025-12-09 | InventisBio Co., Ltd. | Heteroaryl compounds, preparation methods and uses thereof |
| TW202233600A (zh) * | 2021-02-06 | 2022-09-01 | 大陸商正大天晴藥業集團股份有限公司 | 含聯環的ｔｙｋ２抑制劑化合物、藥物組合物及其用途 |
| AU2022222470A1 (en) | 2021-02-19 | 2023-09-21 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| CA3208361A1 (en) | 2021-02-19 | 2022-08-25 | Anjali Pandey | Tyk2 inhibitors and uses thereof |
| EP4294806A1 (en) | 2021-02-19 | 2023-12-27 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| CA3213816A1 (en) * | 2021-03-16 | 2022-09-22 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Amino heteroaryl compounds and compositions |
| CA3223641A1 (en) * | 2021-06-22 | 2022-12-29 | Wenyuan Qian | Sulfoximine compound and use thereof |
| JP2024535865A (ja) * | 2021-07-15 | 2024-10-02 | メッドシャイン ディスカバリー インコーポレイテッド | 硫黄／リン含有アリール系化合物及びその使用 |
| WO2023027948A1 (en) * | 2021-08-21 | 2023-03-02 | Relay Therapeutics, Inc. | Jak2 inhibitors and methods of use thereof |
| EP4423086A1 (en) | 2021-10-25 | 2024-09-04 | Kymera Therapeutics, Inc. | Tyk2 degraders and uses thereof |
| CN116283928A (zh) * | 2021-12-20 | 2023-06-23 | 艾立康药业股份有限公司 | 一种哒嗪类化合物、其制备方法和应用 |
| JP2025511160A (ja) * | 2022-04-01 | 2025-04-15 | サノフイ | ピラゾロピラジノン化合物、その調製のための方法及びその治療的使用 |
| WO2023227946A1 (en) * | 2022-05-27 | 2023-11-30 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| WO2024044486A1 (en) * | 2022-08-22 | 2024-02-29 | Ajax Therapeutics, Inc. | Jak2 inhibitor compounds |
| CN120239699A (zh) * | 2022-12-22 | 2025-07-01 | 祐森健恒生物医药（上海）有限公司 | 一种吡啶多取代化合物的盐型、晶型及其制备方法 |
| WO2026032374A1 (zh) * | 2024-08-07 | 2026-02-12 | 正大天晴药业集团股份有限公司 | 含联环的化合物用于治疗银屑病的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102233252B1 (ko) * | 2012-11-08 | 2021-03-26 | 브리스톨-마이어스 스큅 컴퍼니 | ＩＬ-12, ＩＬ-23 및/또는 ＩＦＮα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물 |
| LT3495358T (lt) * | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| TWI582077B (zh) * | 2013-11-07 | 2017-05-11 | 必治妥美雅史谷比公司 | 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物 |
| AU2019373203B2 (en) * | 2018-10-30 | 2024-10-24 | Bristol-Myers Squibb Company | Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha |
| CN115448910B (zh) * | 2019-01-28 | 2024-04-19 | 江苏豪森药业集团有限公司 | 一种哒嗪类衍生物抑制剂、其制备方法和应用 |
-
2021
- 2021-04-27 KR KR1020227041017A patent/KR20230004771A/ko active Pending
- 2021-04-27 US US17/997,288 patent/US12479831B2/en active Active
- 2021-04-27 JP JP2022565827A patent/JP2023523438A/ja active Pending
- 2021-04-27 EP EP21725357.4A patent/EP4143180A1/en not_active Withdrawn
- 2021-04-27 CN CN202180043740.1A patent/CN115715287A/zh active Pending
- 2021-04-27 WO PCT/US2021/029272 patent/WO2021222153A1/en not_active Ceased